Dr. Vinnedge tests novel breast cancer therapeutics and works to identify biomarkers of disease and disease progression from patient samples.

Miranda Shephard has a BS in biological sciences from Northern Kentucky University and joined the lab in 2016 as a research assistant. She uses cell culture and mouse models to study the oncogenic roles of DEK and how DEK expression creates downstream paracrine signals to create a pro-tumorigenic micro environment.

Evan Page joined the team in the spring of 2022 as a student II position. He is currently a senior at Northern Kentucky University and is pursuing a degree in biological sciences with a focus in biochemistry. He provides valuable technical assistance to support the lab and studies the oncogenic mechanisms of DEK over-expression.